» Articles » PMID: 36185275

Commentary: The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cancer

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Oct 3
PMID 36185275
Authors
Affiliations
Soon will be listed here.
Citing Articles

Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence.

Granata V, Fusco R, Setola S, Galdiero R, Maggialetti N, Silvestro L Cancers (Basel). 2023; 15(2).

PMID: 36672301 PMC: 9857317. DOI: 10.3390/cancers15020351.

References
1.
Granata V, Fusco R, Salati S, Petrillo A, Di Bernardo E, Grassi R . A Systematic Review about Imaging and Histopathological Findings for Detecting and Evaluating Electroporation Based Treatments Response. Int J Environ Res Public Health. 2021; 18(11). PMC: 8197272. DOI: 10.3390/ijerph18115592. View

2.
Kwon J, Chung M, Park J, Lee H, Hwang H, Kang C . Initial experience of irreversible electroporation for locally advanced pancreatic cancer in a Korean population. Acta Radiol. 2020; 62(2):164-171. DOI: 10.1177/0284185120917118. View

3.
Izzo F, Granata V, Fusco R, DAlessio V, Petrillo A, Lastoria S . Clinical Phase I/II Study: Local Disease Control and Survival in Locally Advanced Pancreatic Cancer Treated with Electrochemotherapy. J Clin Med. 2021; 10(6). PMC: 8005134. DOI: 10.3390/jcm10061305. View

4.
Yang P, Huang K, Pua U, Kim M, Li S, Li X . Prognostic factor analysis of irreversible electroporation for locally advanced pancreatic cancer - A multi-institutional clinical study in Asia. Eur J Surg Oncol. 2019; 46(5):811-817. DOI: 10.1016/j.ejso.2019.12.006. View

5.
Benedetti G, Mori M, Panzeri M, Barbera M, Palumbo D, Sini C . CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors. Radiol Med. 2021; 126(6):745-760. DOI: 10.1007/s11547-021-01333-z. View